TRIM28 haploinsufficiency predisposes to Wilms tumor

Autor: Bernt Popp, Abbas Agaimy, Georgia Vasileiou, Marjolijn C.J. Jongmans, Illja J. Diets, Nel Roeleveld, Nicoline Hoogerbrugge, Markus Metzler, Denisa Ilencikova, Roland P. Kuiper, Annelies M. C. Mavinkurve-Groothuis, Didem Seven, Steffen Uebe, Arif B. Ekici, Jenny Wegert, Rajith Bhaskaran, Esmé Waanders, Manfred Gessler, Christian Thiel, Juliane Hoyer, Ronald R. de Krijger, André Reis, Norbert Graf, Simon V. van Reijmersdal, Christian Vokuhl, Michel V. Hadjihannas
Přispěvatelé: İÜC
Rok vydání: 2019
Předmět:
Male
Haploinsufficiency/genetics
Cancer Research
Carcinogenesis
Whole Exome Sequencing/methods
lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4]
Loss of Heterozygosity
Haploinsufficiency
Tripartite Motif-Containing Protein 28
medicine.disease_cause
Germ-Line Mutation/genetics
Kidney Neoplasms/genetics
Germline
Loss of Function Mutation/genetics
0302 clinical medicine
Loss of Function Mutation
Tumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14]
Child
Non-U.S. Gov't
Exome sequencing
Genetic Predisposition to Disease/genetics
Research Support
Non-U.S. Gov't

Wilms tumor
Wilms Tumor/physiology
DNA
Neoplasm

Kidney Neoplasms
Oncology
Child
Preschool

030220 oncology & carcinogenesis
Female
Heterozygote
Genes
Wilms Tumor

Mitotic crossover
Genotype
Tumor suppressor gene
DNA repair
Biology
Research Support
Wilms Tumor
03 medical and health sciences
Exome Sequencing
Journal Article
medicine
Humans
Genetic Predisposition to Disease
Preschool
DNA
Neoplasm/genetics

Germ-Line Mutation
Genes
Wilms Tumor/physiology

Neoplasm/genetics
Loss of Heterozygosity/genetics
TRIM28
Infant
Wilms' tumor
DNA
medicine.disease
haploinsufficiency
Wilms Tumor/genetics
Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10]
Genes
Tripartite Motif-Containing Protein 28/genetics
Cancer research
Carcinogenesis/genetics
genetic predisposition
Zdroj: International Journal of Cancer, 145, 4, pp. 941-951
International Journal of Cancer, 145, 941-951
International Journal of Cancer, 145(4), 941. Wiley-Liss Inc.
ISSN: 0020-7136
DOI: 10.1002/ijc.32167
Popis: Graf, Norbert/0000-0002-2248-323X; Reis, Andre/0000-0002-6301-6363; Diets, Illja/0000-0001-7603-8898; Popp, Bernt/0000-0002-3679-1081; Thiel, Christian T/0000-0003-3817-7277; Roeleveld, Nel/0000-0002-3390-4466; Reis, AlessanRSS/0000-0001-8486-7469; Vasileiou, Georgia/0000-0002-1993-1134; Gessler, Manfred/0000-0002-7915-6045 WOS:000472571300008 PubMed ID: 30694527 Two percent of patients with Wilms tumors have a positive family history. In many of these cases the genetic cause remains unresolved. By applying germline exome sequencing in two families with two affected individuals with Wilms tumors, we identified truncating mutations in TRIM28. Subsequent mutational screening of germline and tumor DNA of 269 children affected by Wilms tumor was performed, and revealed seven additional individuals with germline truncating mutations, and one individual with a somatic truncating mutation in TRIM28. TRIM28 encodes a complex scaffold protein involved in many different processes, including gene silencing, DNA repair and maintenance of genomic integrity. Expression studies on mRNA and protein level showed reduction of TRIM28, confirming a loss-of-function effect of the mutations identified. The tumors showed an epithelial-type histology that stained negative for TRIM28 by immunohistochemistry. The tumors were bilateral in six patients, and 10/11 tumors are accompanied by perilobar nephrogenic rests. Exome sequencing on eight tumor DNA samples from six individuals showed loss-of-heterozygosity (LOH) of the TRIM28-locus by mitotic recombination in seven tumors, suggesting that TRIM28 functions as a tumor suppressor gene in Wilms tumor development. Additionally, the tumors showed very few mutations in known Wilms tumor driver genes, suggesting that loss of TRIM28 is the main driver of tumorigenesis. In conclusion, we identified heterozygous germline truncating mutations in TRIM28 in 11 children with mainly epithelial-type Wilms tumors, which become homozygous in tumor tissue. These data establish TRIM28 as a novel Wilms tumor predisposition gene, acting as a tumor suppressor gene by LOH. Dutch Cancer SocietyKWF Kankerbestrijding [KUN2012-5366]; KiKa Foundation [127] Grant sponsor: Dutch Cancer Society; Grant number: KUN2012-5366; Grant sponsor: The KiKa Foundation (project 127)
Databáze: OpenAIRE